Welcome to The Pharmacogenomics Journal
The Pharmacogenomics Journal is dedicated to the rapid publication of original research on basic pharmacogenomics research and its clinical applications. Publishing six times a year, the journal aims to provide the highest caliber of coverage concerning the effects of genetic variablity on drug toxicity and efficacy, the characterization of polymorphisms relevant to drug action, and the identification of novel genomic targets for drug development.
Free online issue
Volume 8, No 4
August 2008
ISSN: 1470-269X
EISSN: 1473-1150
Impact Factor 4.968*
16/205 in Pharmacology & Pharmacy
20/132 Genetics & Heredity
Editor:
Julio Licinio, MD
*2007 Journal Citation Report (Thomson Reuters, 2008)
FEATURED ARTICLES
REVIEW
A review of gene-drug interactions for non-steroidal anti-inflammatory FREEORIGINAL ARTICLE
Pharmacogenomic Associations in ABCB1 and CYP3A5 with Acute Kidney FREEORIGINAL ARTICLE
Influence of fluorouracil outcome parameters on tolerance and efficacy FREEORIGINAL ARTICLE
Characterization of novel CYP2C8 haplotypes and their contribution FREEORIGINAL ARTICLE
Pharmacogenetic profiling in patients with advanced colorectal cancer FREENEWS
Disease complexity and drug safety. Using Alzheimer's disease as a model of tackling complex pharmacogenetics issues, a review article by Roses et al. discusses how pharmacogenetics affects pipelines and phases of drug development.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- Tonometer disinfection practice in the United Kingdom: A national survey Source: Eye
- Towards a cyberinfrastructure for the biological sciences: progress, visions and challenges & companion wiki page Source: Nature Reviews Genetics
- Amplitude spectroscopy of a solid-state artificial atom Source: Nature